Recipharm Launches Stand-Alone Serialization Service

By Akia Thorpe -

July 10, 2018

Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has launched a stand-alone serialization service for meeting a compliance deadline of February 2019 for certain requirements of the European Union Falsified Medicines Directive (FMD), which sees to counteract the spread of counterfeit medicines.

Recipharm will be able to add 2D codes, human readable text, and tamper evidence to pre-packed medicines using existing equipment across its facilities.

The offering is the latest phase in Recipharm’s company-wide serialization project, which was launched in 2016 following a EUR 40 million investment ($46 million).

Source: Recipharm